nodes	percent_of_prediction	percent_of_DWPC	metapath
Methadone—CYP2C9—brain cancer	0.511	1	CbGaD
Methadone—CYP2D6—Lomustine—brain cancer	0.0515	0.178	CbGbCtD
Methadone—CYP1A2—Carmustine—brain cancer	0.051	0.176	CbGbCtD
Methadone—CYP2D6—Hydroxyurea—brain cancer	0.0391	0.135	CbGbCtD
Methadone—CYP3A4—Temozolomide—brain cancer	0.0385	0.133	CbGbCtD
Methadone—CYP3A4—Lomustine—brain cancer	0.0328	0.113	CbGbCtD
Methadone—CYP3A5—Etoposide—brain cancer	0.0203	0.0703	CbGbCtD
Methadone—CYP2C8—Etoposide—brain cancer	0.0195	0.0676	CbGbCtD
Methadone—CYP1A2—Etoposide—brain cancer	0.0151	0.0523	CbGbCtD
Methadone—ABCB1—Etoposide—brain cancer	0.0132	0.0457	CbGbCtD
Methadone—HTR3A—fourth ventricle—brain cancer	0.0117	0.178	CbGeAlD
Methadone—CHRNA10—internal ear—brain cancer	0.0109	0.166	CbGeAlD
Methadone—CYP3A4—Etoposide—brain cancer	0.00792	0.0274	CbGbCtD
Methadone—HTR3A—cranial nerve—brain cancer	0.00418	0.0634	CbGeAlD
Methadone—OPRM1—telencephalic ventricle—brain cancer	0.00312	0.0473	CbGeAlD
Methadone—OPRD1—ganglion—brain cancer	0.00284	0.0432	CbGeAlD
Methadone—HTR3A—ganglion—brain cancer	0.00212	0.0321	CbGeAlD
Methadone—Phlebitis—Carboplatin—brain cancer	0.00196	0.0246	CcSEcCtD
Methadone—OPRM1—ganglion—brain cancer	0.00194	0.0294	CbGeAlD
Methadone—Intracranial pressure increased—Carmustine—brain cancer	0.00193	0.0243	CcSEcCtD
Methadone—Disorientation—Lomustine—brain cancer	0.00165	0.0208	CcSEcCtD
Methadone—Hypomagnesaemia—Hydroxyurea—brain cancer	0.00157	0.0198	CcSEcCtD
Methadone—GRIN3A—telencephalon—brain cancer	0.00156	0.0236	CbGeAlD
Methadone—Visual disturbance—Lomustine—brain cancer	0.00156	0.0196	CcSEcCtD
Methadone—Amenorrhoea—Procarbazine—brain cancer	0.00147	0.0185	CcSEcCtD
Methadone—Amenorrhoea—Hydroxyurea—brain cancer	0.00114	0.0143	CcSEcCtD
Methadone—Lung disorder—Temozolomide—brain cancer	0.0011	0.0139	CcSEcCtD
Methadone—CHRNA10—head—brain cancer	0.0011	0.0167	CbGeAlD
Methadone—OPRD1—telencephalon—brain cancer	0.0011	0.0167	CbGeAlD
Methadone—Disorientation—Procarbazine—brain cancer	0.00105	0.0132	CcSEcCtD
Methadone—Visual impairment—Lomustine—brain cancer	0.000983	0.0124	CcSEcCtD
Methadone—GRIN3A—head—brain cancer	0.00097	0.0147	CbGeAlD
Methadone—HTR3A—brainstem—brain cancer	0.00092	0.014	CbGeAlD
Methadone—Pulmonary oedema—Hydroxyurea—brain cancer	0.000889	0.0112	CcSEcCtD
Methadone—Amenorrhoea—Temozolomide—brain cancer	0.000888	0.0112	CcSEcCtD
Methadone—GRIN3A—central nervous system—brain cancer	0.000885	0.0134	CbGeAlD
Methadone—Drug interaction—Carmustine—brain cancer	0.00087	0.011	CcSEcCtD
Methadone—OPRM1—brainstem—brain cancer	0.000843	0.0128	CbGeAlD
Methadone—HTR3A—telencephalon—brain cancer	0.000816	0.0124	CbGeAlD
Methadone—Disorientation—Hydroxyurea—brain cancer	0.00081	0.0102	CcSEcCtD
Methadone—Sweating increased—Procarbazine—brain cancer	0.000788	0.00993	CcSEcCtD
Methadone—CYP2C18—endocrine gland—brain cancer	0.000765	0.0116	CbGeAlD
Methadone—OPRM1—telencephalon—brain cancer	0.000748	0.0114	CbGeAlD
Methadone—CYP3A7—endocrine gland—brain cancer	0.000728	0.011	CbGeAlD
Methadone—Drowsiness—Procarbazine—brain cancer	0.000722	0.00909	CcSEcCtD
Methadone—Thrombocytopenia—Lomustine—brain cancer	0.00071	0.00894	CcSEcCtD
Methadone—Pain—Carboplatin—brain cancer	0.000709	0.00892	CcSEcCtD
Methadone—GRIN3A—brain—brain cancer	0.000703	0.0107	CbGeAlD
Methadone—Sweating—Procarbazine—brain cancer	0.000692	0.00871	CcSEcCtD
Methadone—Anorexia—Lomustine—brain cancer	0.000691	0.0087	CcSEcCtD
Methadone—Oxaprozin—CYP2C9—brain cancer	0.000688	0.194	CrCbGaD
Methadone—OPRD1—head—brain cancer	0.000683	0.0104	CbGeAlD
Methadone—Phlebitis—Carmustine—brain cancer	0.00068	0.00856	CcSEcCtD
Methadone—Swelling—Carmustine—brain cancer	0.000664	0.00836	CcSEcCtD
Methadone—Body temperature increased—Carboplatin—brain cancer	0.000655	0.00825	CcSEcCtD
Methadone—OPRK1—head—brain cancer	0.000655	0.00994	CbGeAlD
Methadone—Hallucination—Procarbazine—brain cancer	0.000645	0.00812	CcSEcCtD
Methadone—Decreased appetite—Lomustine—brain cancer	0.00063	0.00794	CcSEcCtD
Methadone—OPRD1—central nervous system—brain cancer	0.000624	0.00947	CbGeAlD
Methadone—Flushing—Procarbazine—brain cancer	0.000601	0.00757	CcSEcCtD
Methadone—OPRK1—central nervous system—brain cancer	0.000598	0.00907	CbGeAlD
Methadone—CYP2D6—hindbrain—brain cancer	0.00059	0.00895	CbGeAlD
Methadone—OPRK1—cerebellum—brain cancer	0.000584	0.00887	CbGeAlD
Methadone—Chills—Procarbazine—brain cancer	0.000581	0.00732	CcSEcCtD
Methadone—Arrhythmia—Procarbazine—brain cancer	0.000579	0.00729	CcSEcCtD
Methadone—Body temperature increased—Lomustine—brain cancer	0.000573	0.00722	CcSEcCtD
Methadone—Weight increased—Hydroxyurea—brain cancer	0.00057	0.00718	CcSEcCtD
Methadone—Drowsiness—Hydroxyurea—brain cancer	0.000559	0.00703	CcSEcCtD
Methadone—OPRM1—midbrain—brain cancer	0.000537	0.00816	CbGeAlD
Methadone—Hypokalaemia—Carmustine—brain cancer	0.000533	0.00671	CcSEcCtD
Methadone—Tremor—Procarbazine—brain cancer	0.000528	0.00665	CcSEcCtD
Methadone—Phlebitis—Etoposide—brain cancer	0.000526	0.00662	CcSEcCtD
Methadone—CYP19A1—gonad—brain cancer	0.000525	0.00796	CbGeAlD
Methadone—OPRM1—spinal cord—brain cancer	0.000524	0.00796	CbGeAlD
Methadone—Hypokalaemia—Temozolomide—brain cancer	0.000515	0.00649	CcSEcCtD
Methadone—Swelling—Etoposide—brain cancer	0.000514	0.00647	CcSEcCtD
Methadone—HTR3A—head—brain cancer	0.000508	0.00771	CbGeAlD
Methadone—Syncope—Procarbazine—brain cancer	0.000506	0.00637	CcSEcCtD
Methadone—Hallucination—Hydroxyurea—brain cancer	0.000499	0.00628	CcSEcCtD
Methadone—Loss of consciousness—Procarbazine—brain cancer	0.000496	0.00624	CcSEcCtD
Methadone—OPRD1—brain—brain cancer	0.000495	0.00751	CbGeAlD
Methadone—Convulsion—Procarbazine—brain cancer	0.000489	0.00615	CcSEcCtD
Methadone—Anxiety—Procarbazine—brain cancer	0.000478	0.00602	CcSEcCtD
Methadone—Sweating increased—Temozolomide—brain cancer	0.000477	0.006	CcSEcCtD
Methadone—OPRK1—brain—brain cancer	0.000475	0.0072	CbGeAlD
Methadone—OPRM1—endocrine gland—brain cancer	0.000472	0.00716	CbGeAlD
Methadone—Dry mouth—Procarbazine—brain cancer	0.00047	0.00591	CcSEcCtD
Methadone—OPRM1—head—brain cancer	0.000466	0.00707	CbGeAlD
Methadone—Cardiac failure—Etoposide—brain cancer	0.000464	0.00585	CcSEcCtD
Methadone—Confusional state—Procarbazine—brain cancer	0.000464	0.00584	CcSEcCtD
Methadone—HTR3A—central nervous system—brain cancer	0.000464	0.00704	CbGeAlD
Methadone—Vomiting—Lomustine—brain cancer	0.000461	0.0058	CcSEcCtD
Methadone—Oedema—Procarbazine—brain cancer	0.00046	0.0058	CcSEcCtD
Methadone—Phenylbutazone—CYP2C9—brain cancer	0.000455	0.128	CrCbGaD
Methadone—Shock—Procarbazine—brain cancer	0.000453	0.0057	CcSEcCtD
Methadone—Thrombocytopenia—Procarbazine—brain cancer	0.000451	0.00567	CcSEcCtD
Methadone—Chills—Hydroxyurea—brain cancer	0.00045	0.00566	CcSEcCtD
Methadone—Tachycardia—Procarbazine—brain cancer	0.000449	0.00566	CcSEcCtD
Methadone—Weight increased—Temozolomide—brain cancer	0.000445	0.00561	CcSEcCtD
Methadone—Hyperhidrosis—Procarbazine—brain cancer	0.000445	0.0056	CcSEcCtD
Methadone—ABCB1—blood vessel—brain cancer	0.000445	0.00675	CbGeAlD
Methadone—Weight decreased—Temozolomide—brain cancer	0.000443	0.00557	CcSEcCtD
Methadone—Anorexia—Procarbazine—brain cancer	0.000439	0.00552	CcSEcCtD
Methadone—Erythema—Hydroxyurea—brain cancer	0.000436	0.0055	CcSEcCtD
Methadone—Cardiac arrest—Etoposide—brain cancer	0.000431	0.00542	CcSEcCtD
Methadone—Nausea—Lomustine—brain cancer	0.000431	0.00542	CcSEcCtD
Methadone—Hypotension—Procarbazine—brain cancer	0.00043	0.00542	CcSEcCtD
Methadone—OPRM1—central nervous system—brain cancer	0.000425	0.00646	CbGeAlD
Methadone—Insomnia—Procarbazine—brain cancer	0.000416	0.00524	CcSEcCtD
Methadone—Somnolence—Procarbazine—brain cancer	0.000409	0.00515	CcSEcCtD
Methadone—Clotrimazole—CYP2C9—brain cancer	0.000408	0.115	CrCbGaD
Methadone—Hallucination—Carmustine—brain cancer	0.000403	0.00508	CcSEcCtD
Methadone—Decreased appetite—Procarbazine—brain cancer	0.0004	0.00504	CcSEcCtD
Methadone—CYP19A1—endocrine gland—brain cancer	0.000397	0.00602	CbGeAlD
Methadone—Pain—Procarbazine—brain cancer	0.000394	0.00496	CcSEcCtD
Methadone—Constipation—Procarbazine—brain cancer	0.000394	0.00496	CcSEcCtD
Methadone—CYP19A1—head—brain cancer	0.000391	0.00594	CbGeAlD
Methadone—Visual impairment—Carmustine—brain cancer	0.000391	0.00492	CcSEcCtD
Methadone—Hallucination—Temozolomide—brain cancer	0.00039	0.00491	CcSEcCtD
Methadone—Sweating increased—Etoposide—brain cancer	0.000381	0.0048	CcSEcCtD
Methadone—Feeling abnormal—Procarbazine—brain cancer	0.000379	0.00478	CcSEcCtD
Methadone—Convulsion—Hydroxyurea—brain cancer	0.000378	0.00476	CcSEcCtD
Methadone—Visual impairment—Temozolomide—brain cancer	0.000377	0.00475	CcSEcCtD
Methadone—Gastrointestinal pain—Procarbazine—brain cancer	0.000376	0.00474	CcSEcCtD
Methadone—Flushing—Carmustine—brain cancer	0.000376	0.00474	CcSEcCtD
Methadone—HTR3A—brain—brain cancer	0.000368	0.00559	CbGeAlD
Methadone—CYP2C8—pituitary gland—brain cancer	0.000366	0.00556	CbGeAlD
Methadone—Urticaria—Procarbazine—brain cancer	0.000366	0.0046	CcSEcCtD
Methadone—Abdominal pain—Procarbazine—brain cancer	0.000364	0.00458	CcSEcCtD
Methadone—Body temperature increased—Procarbazine—brain cancer	0.000364	0.00458	CcSEcCtD
Methadone—Flushing—Temozolomide—brain cancer	0.000364	0.00458	CcSEcCtD
Methadone—Arrhythmia—Carmustine—brain cancer	0.000362	0.00456	CcSEcCtD
Methadone—CYP19A1—central nervous system—brain cancer	0.000357	0.00542	CbGeAlD
Methadone—Modafinil—CYP2C9—brain cancer	0.000356	0.1	CrCbGaD
Methadone—Oedema—Hydroxyurea—brain cancer	0.000356	0.00449	CcSEcCtD
Methadone—Erythema—Carmustine—brain cancer	0.000353	0.00444	CcSEcCtD
Methadone—Dextropropoxyphene—CYP2C9—brain cancer	0.000352	0.0992	CrCbGaD
Methadone—Chills—Temozolomide—brain cancer	0.000351	0.00443	CcSEcCtD
Methadone—Thrombocytopenia—Hydroxyurea—brain cancer	0.000349	0.00439	CcSEcCtD
Methadone—Erythema—Temozolomide—brain cancer	0.000341	0.00429	CcSEcCtD
Methadone—Anorexia—Hydroxyurea—brain cancer	0.00034	0.00428	CcSEcCtD
Methadone—Hypersensitivity—Procarbazine—brain cancer	0.000339	0.00427	CcSEcCtD
Methadone—CYP2D6—brainstem—brain cancer	0.000338	0.00513	CbGeAlD
Methadone—OPRM1—brain—brain cancer	0.000338	0.00512	CbGeAlD
Methadone—CYP2B6—gonad—brain cancer	0.000337	0.00511	CbGeAlD
Methadone—Tremor—Carmustine—brain cancer	0.000331	0.00416	CcSEcCtD
Methadone—Asthenia—Procarbazine—brain cancer	0.00033	0.00416	CcSEcCtD
Methadone—Pruritus—Procarbazine—brain cancer	0.000326	0.0041	CcSEcCtD
Methadone—CYP2C19—endocrine gland—brain cancer	0.000325	0.00494	CbGeAlD
Methadone—Agitation—Carmustine—brain cancer	0.000324	0.00408	CcSEcCtD
Methadone—Tremor—Temozolomide—brain cancer	0.000319	0.00402	CcSEcCtD
Methadone—Somnolence—Hydroxyurea—brain cancer	0.000317	0.00399	CcSEcCtD
Methadone—Diarrhoea—Procarbazine—brain cancer	0.000315	0.00397	CcSEcCtD
Methadone—Agitation—Temozolomide—brain cancer	0.000313	0.00395	CcSEcCtD
Methadone—Decreased appetite—Hydroxyurea—brain cancer	0.00031	0.0039	CcSEcCtD
Methadone—Tamoxifen—ESR2—brain cancer	0.000307	0.0865	CrCbGaD
Methadone—Vertigo—Temozolomide—brain cancer	0.000306	0.00386	CcSEcCtD
Methadone—Convulsion—Carmustine—brain cancer	0.000306	0.00385	CcSEcCtD
Methadone—Pain—Hydroxyurea—brain cancer	0.000305	0.00384	CcSEcCtD
Methadone—Constipation—Hydroxyurea—brain cancer	0.000305	0.00384	CcSEcCtD
Methadone—Dizziness—Procarbazine—brain cancer	0.000304	0.00383	CcSEcCtD
Methadone—Palpitations—Temozolomide—brain cancer	0.000301	0.00379	CcSEcCtD
Methadone—CYP2D6—telencephalon—brain cancer	0.0003	0.00455	CbGeAlD
Methadone—Anxiety—Carmustine—brain cancer	0.000299	0.00377	CcSEcCtD
Methadone—Convulsion—Temozolomide—brain cancer	0.000295	0.00372	CcSEcCtD
Methadone—Feeling abnormal—Hydroxyurea—brain cancer	0.000294	0.0037	CcSEcCtD
Methadone—Vomiting—Procarbazine—brain cancer	0.000293	0.00368	CcSEcCtD
Methadone—Flushing—Etoposide—brain cancer	0.000291	0.00366	CcSEcCtD
Methadone—Confusional state—Carmustine—brain cancer	0.00029	0.00366	CcSEcCtD
Methadone—Rash—Procarbazine—brain cancer	0.00029	0.00365	CcSEcCtD
Methadone—Dermatitis—Procarbazine—brain cancer	0.00029	0.00365	CcSEcCtD
Methadone—Anxiety—Temozolomide—brain cancer	0.000289	0.00364	CcSEcCtD
Methadone—Headache—Procarbazine—brain cancer	0.000288	0.00363	CcSEcCtD
Methadone—Oedema—Carmustine—brain cancer	0.000288	0.00363	CcSEcCtD
Methadone—Dry mouth—Temozolomide—brain cancer	0.000284	0.00357	CcSEcCtD
Methadone—CYP2C8—endocrine gland—brain cancer	0.000284	0.00431	CbGeAlD
Methadone—CYP19A1—brain—brain cancer	0.000284	0.00431	CbGeAlD
Methadone—Thrombocytopenia—Carmustine—brain cancer	0.000282	0.00355	CcSEcCtD
Methadone—Body temperature increased—Hydroxyurea—brain cancer	0.000282	0.00355	CcSEcCtD
Methadone—Chills—Etoposide—brain cancer	0.000281	0.00354	CcSEcCtD
Methadone—Tachycardia—Carmustine—brain cancer	0.000281	0.00354	CcSEcCtD
Methadone—Confusional state—Temozolomide—brain cancer	0.000281	0.00353	CcSEcCtD
Methadone—Anaphylactic shock—Temozolomide—brain cancer	0.000278	0.0035	CcSEcCtD
Methadone—Oedema—Temozolomide—brain cancer	0.000278	0.0035	CcSEcCtD
Methadone—Anorexia—Carmustine—brain cancer	0.000275	0.00346	CcSEcCtD
Methadone—Nausea—Procarbazine—brain cancer	0.000273	0.00344	CcSEcCtD
Methadone—Thrombocytopenia—Temozolomide—brain cancer	0.000272	0.00343	CcSEcCtD
Methadone—Hypotension—Carmustine—brain cancer	0.000269	0.00339	CcSEcCtD
Methadone—Hyperhidrosis—Temozolomide—brain cancer	0.000269	0.00339	CcSEcCtD
Methadone—CYP1A2—endocrine gland—brain cancer	0.000266	0.00403	CbGeAlD
Methadone—Anorexia—Temozolomide—brain cancer	0.000265	0.00334	CcSEcCtD
Methadone—Hypersensitivity—Hydroxyurea—brain cancer	0.000262	0.0033	CcSEcCtD
Methadone—Muscle spasms—Etoposide—brain cancer	0.000262	0.0033	CcSEcCtD
Methadone—Insomnia—Carmustine—brain cancer	0.00026	0.00328	CcSEcCtD
Methadone—CYP3A5—endocrine gland—brain cancer	0.000256	0.00389	CbGeAlD
Methadone—Somnolence—Carmustine—brain cancer	0.000256	0.00322	CcSEcCtD
Methadone—Asthenia—Hydroxyurea—brain cancer	0.000256	0.00322	CcSEcCtD
Methadone—CYP2B6—endocrine gland—brain cancer	0.000255	0.00387	CbGeAlD
Methadone—CYP2C9—endocrine gland—brain cancer	0.000252	0.00383	CbGeAlD
Methadone—Trimipramine—CYP2C9—brain cancer	0.000252	0.071	CrCbGaD
Methadone—Insomnia—Temozolomide—brain cancer	0.000252	0.00317	CcSEcCtD
Methadone—CYP2B6—head—brain cancer	0.000251	0.00382	CbGeAlD
Methadone—Decreased appetite—Carmustine—brain cancer	0.00025	0.00315	CcSEcCtD
Methadone—Diphenhydramine—CYP2C9—brain cancer	0.000248	0.0697	CrCbGaD
Methadone—Somnolence—Temozolomide—brain cancer	0.000247	0.00312	CcSEcCtD
Methadone—Constipation—Carmustine—brain cancer	0.000246	0.0031	CcSEcCtD
Methadone—Pain—Carmustine—brain cancer	0.000246	0.0031	CcSEcCtD
Methadone—Vertigo—Etoposide—brain cancer	0.000245	0.00309	CcSEcCtD
Methadone—Diarrhoea—Hydroxyurea—brain cancer	0.000244	0.00307	CcSEcCtD
Methadone—Promethazine—CYP2C9—brain cancer	0.000243	0.0684	CrCbGaD
Methadone—Decreased appetite—Temozolomide—brain cancer	0.000242	0.00305	CcSEcCtD
Methadone—Tamoxifen—CYP2C9—brain cancer	0.000241	0.0679	CrCbGaD
Methadone—Loss of consciousness—Etoposide—brain cancer	0.00024	0.00302	CcSEcCtD
Methadone—Constipation—Temozolomide—brain cancer	0.000238	0.003	CcSEcCtD
Methadone—Pain—Temozolomide—brain cancer	0.000238	0.003	CcSEcCtD
Methadone—Feeling abnormal—Carmustine—brain cancer	0.000237	0.00299	CcSEcCtD
Methadone—Convulsion—Etoposide—brain cancer	0.000236	0.00298	CcSEcCtD
Methadone—Dizziness—Hydroxyurea—brain cancer	0.000236	0.00297	CcSEcCtD
Methadone—Gastrointestinal pain—Carmustine—brain cancer	0.000235	0.00297	CcSEcCtD
Methadone—CYP2B6—central nervous system—brain cancer	0.000229	0.00348	CbGeAlD
Methadone—Feeling abnormal—Temozolomide—brain cancer	0.000229	0.00289	CcSEcCtD
Methadone—Body temperature increased—Carmustine—brain cancer	0.000228	0.00287	CcSEcCtD
Methadone—Abdominal pain—Carmustine—brain cancer	0.000228	0.00287	CcSEcCtD
Methadone—Gastrointestinal pain—Temozolomide—brain cancer	0.000228	0.00287	CcSEcCtD
Methadone—Vomiting—Hydroxyurea—brain cancer	0.000226	0.00285	CcSEcCtD
Methadone—Rash—Hydroxyurea—brain cancer	0.000225	0.00283	CcSEcCtD
Methadone—Confusional state—Etoposide—brain cancer	0.000225	0.00283	CcSEcCtD
Methadone—Dermatitis—Hydroxyurea—brain cancer	0.000224	0.00283	CcSEcCtD
Methadone—Headache—Hydroxyurea—brain cancer	0.000223	0.00281	CcSEcCtD
Methadone—Anaphylactic shock—Etoposide—brain cancer	0.000223	0.0028	CcSEcCtD
Methadone—Urticaria—Temozolomide—brain cancer	0.000221	0.00278	CcSEcCtD
Methadone—Body temperature increased—Temozolomide—brain cancer	0.00022	0.00277	CcSEcCtD
Methadone—Abdominal pain—Temozolomide—brain cancer	0.00022	0.00277	CcSEcCtD
Methadone—Thrombocytopenia—Etoposide—brain cancer	0.000218	0.00275	CcSEcCtD
Methadone—Tachycardia—Etoposide—brain cancer	0.000217	0.00274	CcSEcCtD
Methadone—ABCB1—telencephalon—brain cancer	0.000216	0.00328	CbGeAlD
Methadone—Hyperhidrosis—Etoposide—brain cancer	0.000215	0.00271	CcSEcCtD
Methadone—Anorexia—Etoposide—brain cancer	0.000212	0.00267	CcSEcCtD
Methadone—Hypersensitivity—Carmustine—brain cancer	0.000212	0.00267	CcSEcCtD
Methadone—Nausea—Hydroxyurea—brain cancer	0.000212	0.00266	CcSEcCtD
Methadone—Hypotension—Etoposide—brain cancer	0.000208	0.00262	CcSEcCtD
Methadone—Asthenia—Carmustine—brain cancer	0.000207	0.0026	CcSEcCtD
Methadone—Hypersensitivity—Temozolomide—brain cancer	0.000205	0.00258	CcSEcCtD
Methadone—CYP2C8—brain—brain cancer	0.000203	0.00308	CbGeAlD
Methadone—Asthenia—Temozolomide—brain cancer	0.0002	0.00251	CcSEcCtD
Methadone—Somnolence—Etoposide—brain cancer	0.000198	0.00249	CcSEcCtD
Methadone—Diarrhoea—Carmustine—brain cancer	0.000197	0.00248	CcSEcCtD
Methadone—Pruritus—Temozolomide—brain cancer	0.000197	0.00248	CcSEcCtD
Methadone—Decreased appetite—Etoposide—brain cancer	0.000194	0.00244	CcSEcCtD
Methadone—CYP3A4—endocrine gland—brain cancer	0.000192	0.00292	CbGeAlD
Methadone—Dizziness—Carmustine—brain cancer	0.00019	0.0024	CcSEcCtD
Methadone—Constipation—Etoposide—brain cancer	0.00019	0.0024	CcSEcCtD
Methadone—Pain—Etoposide—brain cancer	0.00019	0.0024	CcSEcCtD
Methadone—Diarrhoea—Temozolomide—brain cancer	0.00019	0.0024	CcSEcCtD
Methadone—CYP2D6—endocrine gland—brain cancer	0.000189	0.00287	CbGeAlD
Methadone—CYP2D6—head—brain cancer	0.000187	0.00284	CbGeAlD
Methadone—Dizziness—Temozolomide—brain cancer	0.000184	0.00232	CcSEcCtD
Methadone—Feeling abnormal—Etoposide—brain cancer	0.000184	0.00231	CcSEcCtD
Methadone—Vomiting—Carmustine—brain cancer	0.000183	0.00231	CcSEcCtD
Methadone—CYP2B6—brain—brain cancer	0.000182	0.00277	CbGeAlD
Methadone—Gastrointestinal pain—Etoposide—brain cancer	0.000182	0.00229	CcSEcCtD
Methadone—Rash—Carmustine—brain cancer	0.000182	0.00229	CcSEcCtD
Methadone—Dermatitis—Carmustine—brain cancer	0.000181	0.00228	CcSEcCtD
Methadone—Headache—Carmustine—brain cancer	0.00018	0.00227	CcSEcCtD
Methadone—ABCB1—gonad—brain cancer	0.00018	0.00273	CbGeAlD
Methadone—Vomiting—Temozolomide—brain cancer	0.000177	0.00223	CcSEcCtD
Methadone—Urticaria—Etoposide—brain cancer	0.000177	0.00223	CcSEcCtD
Methadone—Body temperature increased—Etoposide—brain cancer	0.000176	0.00222	CcSEcCtD
Methadone—Abdominal pain—Etoposide—brain cancer	0.000176	0.00222	CcSEcCtD
Methadone—ABCB1—pituitary gland—brain cancer	0.000176	0.00267	CbGeAlD
Methadone—Rash—Temozolomide—brain cancer	0.000175	0.00221	CcSEcCtD
Methadone—Dermatitis—Temozolomide—brain cancer	0.000175	0.00221	CcSEcCtD
Methadone—Headache—Temozolomide—brain cancer	0.000174	0.0022	CcSEcCtD
Methadone—CYP3A4—central nervous system—brain cancer	0.000173	0.00263	CbGeAlD
Methadone—Nausea—Carmustine—brain cancer	0.000171	0.00215	CcSEcCtD
Methadone—CYP2D6—central nervous system—brain cancer	0.000171	0.00259	CbGeAlD
Methadone—ABCB1—medulla oblongata—brain cancer	0.00017	0.00257	CbGeAlD
Methadone—CYP2D6—cerebellum—brain cancer	0.000167	0.00253	CbGeAlD
Methadone—Nausea—Temozolomide—brain cancer	0.000165	0.00208	CcSEcCtD
Methadone—Hypersensitivity—Etoposide—brain cancer	0.000164	0.00207	CcSEcCtD
Methadone—Asthenia—Etoposide—brain cancer	0.00016	0.00201	CcSEcCtD
Methadone—Pruritus—Etoposide—brain cancer	0.000158	0.00198	CcSEcCtD
Methadone—ABCB1—midbrain—brain cancer	0.000155	0.00235	CbGeAlD
Methadone—Diarrhoea—Etoposide—brain cancer	0.000152	0.00192	CcSEcCtD
Methadone—ABCB1—spinal cord—brain cancer	0.000151	0.00229	CbGeAlD
Methadone—Dizziness—Etoposide—brain cancer	0.000147	0.00185	CcSEcCtD
Methadone—Vomiting—Etoposide—brain cancer	0.000142	0.00178	CcSEcCtD
Methadone—Rash—Etoposide—brain cancer	0.00014	0.00177	CcSEcCtD
Methadone—Dermatitis—Etoposide—brain cancer	0.00014	0.00177	CcSEcCtD
Methadone—Headache—Etoposide—brain cancer	0.00014	0.00176	CcSEcCtD
Methadone—ABCB1—endocrine gland—brain cancer	0.000136	0.00207	CbGeAlD
Methadone—CYP2D6—brain—brain cancer	0.000135	0.00205	CbGeAlD
Methadone—ABCB1—head—brain cancer	0.000134	0.00204	CbGeAlD
Methadone—Nausea—Etoposide—brain cancer	0.000132	0.00167	CcSEcCtD
Methadone—ABCB1—central nervous system—brain cancer	0.000123	0.00186	CbGeAlD
Methadone—ABCB1—cerebellum—brain cancer	0.00012	0.00182	CbGeAlD
Methadone—ABCB1—brain—brain cancer	9.74e-05	0.00148	CbGeAlD
Methadone—OPRK1—GPCR downstream signaling—ABR—brain cancer	6.02e-05	0.00117	CbGpPWpGaD
Methadone—OPRM1—GPCR ligand binding—SHH—brain cancer	5.91e-05	0.00115	CbGpPWpGaD
Methadone—OPRM1—Signaling by GPCR—PTCH2—brain cancer	5.89e-05	0.00114	CbGpPWpGaD
Methadone—OPRM1—GPCR ligand binding—SMO—brain cancer	5.6e-05	0.00109	CbGpPWpGaD
Methadone—OPRM1—GPCR ligand binding—PTCH1—brain cancer	5.6e-05	0.00109	CbGpPWpGaD
Methadone—OPRK1—Signaling by GPCR—ABR—brain cancer	5.47e-05	0.00106	CbGpPWpGaD
Methadone—OPRK1—Signaling Pathways—DTX2—brain cancer	5.43e-05	0.00105	CbGpPWpGaD
Methadone—ABCB1—Integrated Pancreatic Cancer Pathway—SHH—brain cancer	5.41e-05	0.00105	CbGpPWpGaD
Methadone—OPRM1—Signaling Pathways—OR4C12—brain cancer	5.4e-05	0.00105	CbGpPWpGaD
Methadone—OPRM1—Signaling Pathways—OR14C36—brain cancer	5.4e-05	0.00105	CbGpPWpGaD
Methadone—ABCB1—Integrated Pancreatic Cancer Pathway—SMO—brain cancer	5.13e-05	0.000995	CbGpPWpGaD
Methadone—OPRM1—GPCR downstream signaling—ABR—brain cancer	5.09e-05	0.000988	CbGpPWpGaD
Methadone—CYP1A2—Aryl Hydrocarbon Receptor—RELA—brain cancer	4.83e-05	0.000938	CbGpPWpGaD
Methadone—CYP2C18—Metabolism—CYP2C9—brain cancer	4.8e-05	0.000932	CbGpPWpGaD
Methadone—OPRD1—Signaling Pathways—PTCH2—brain cancer	4.69e-05	0.000912	CbGpPWpGaD
Methadone—OPRM1—Signaling by GPCR—ABR—brain cancer	4.62e-05	0.000897	CbGpPWpGaD
Methadone—OPRM1—Signaling Pathways—DTX2—brain cancer	4.59e-05	0.000891	CbGpPWpGaD
Methadone—OPRD1—Signaling Pathways—HES5—brain cancer	4.55e-05	0.000883	CbGpPWpGaD
Methadone—CYP2C8—Metabolism of lipids and lipoproteins—CYP2C9—brain cancer	4.48e-05	0.000871	CbGpPWpGaD
Methadone—ABCB1—Transmembrane transport of small molecules—S100A10—brain cancer	4.48e-05	0.000871	CbGpPWpGaD
Methadone—OPRD1—Signaling Pathways—STRADA—brain cancer	4.41e-05	0.000857	CbGpPWpGaD
Methadone—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL2—brain cancer	4.35e-05	0.000845	CbGpPWpGaD
Methadone—OPRD1—GPCR downstream signaling—TRPC6—brain cancer	4.35e-05	0.000844	CbGpPWpGaD
Methadone—CYP19A1—Integrated Breast Cancer Pathway—CCND1—brain cancer	4.34e-05	0.000842	CbGpPWpGaD
Methadone—ABCB1—Integrated Pancreatic Cancer Pathway—ESR2—brain cancer	4.33e-05	0.00084	CbGpPWpGaD
Methadone—CYP19A1—Integrated Breast Cancer Pathway—CTNNB1—brain cancer	4.29e-05	0.000834	CbGpPWpGaD
Methadone—OPRK1—Signaling Pathways—PTCH2—brain cancer	4.12e-05	0.000799	CbGpPWpGaD
Methadone—OPRD1—Signaling by GPCR—SHH—brain cancer	4.09e-05	0.000795	CbGpPWpGaD
Methadone—CYP2C18—Metabolism—BSG—brain cancer	4.08e-05	0.000792	CbGpPWpGaD
Methadone—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—brain cancer	4.05e-05	0.000787	CbGpPWpGaD
Methadone—CYP2C19—Metabolism of lipids and lipoproteins—CYP2C9—brain cancer	4e-05	0.000777	CbGpPWpGaD
Methadone—OPRK1—Signaling Pathways—HES5—brain cancer	3.99e-05	0.000774	CbGpPWpGaD
Methadone—OPRD1—Signaling by GPCR—TRPC6—brain cancer	3.95e-05	0.000767	CbGpPWpGaD
Methadone—OPRD1—Signaling by GPCR—SMO—brain cancer	3.88e-05	0.000754	CbGpPWpGaD
Methadone—OPRD1—Signaling by GPCR—PTCH1—brain cancer	3.88e-05	0.000754	CbGpPWpGaD
Methadone—OPRK1—Signaling Pathways—STRADA—brain cancer	3.87e-05	0.000752	CbGpPWpGaD
Methadone—OPRK1—GPCR downstream signaling—TRPC6—brain cancer	3.81e-05	0.00074	CbGpPWpGaD
Methadone—CYP19A1—Integrated Breast Cancer Pathway—VEGFA—brain cancer	3.78e-05	0.000734	CbGpPWpGaD
Methadone—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—brain cancer	3.7e-05	0.000718	CbGpPWpGaD
Methadone—OPRD1—Signaling Pathways—ABR—brain cancer	3.68e-05	0.000715	CbGpPWpGaD
Methadone—CYP19A1—Metabolism—CYP2C9—brain cancer	3.67e-05	0.000713	CbGpPWpGaD
Methadone—OPRK1—Signaling by GPCR—SHH—brain cancer	3.59e-05	0.000697	CbGpPWpGaD
Methadone—OPRD1—Signaling Pathways—GLI2—brain cancer	3.56e-05	0.000691	CbGpPWpGaD
Methadone—ABCB1—Integrated Pancreatic Cancer Pathway—BRCA2—brain cancer	3.55e-05	0.00069	CbGpPWpGaD
Methadone—ABCB1—Allograft Rejection—IL2—brain cancer	3.54e-05	0.000687	CbGpPWpGaD
Methadone—CYP2C18—Metabolism—IDH1—brain cancer	3.51e-05	0.000681	CbGpPWpGaD
Methadone—ABCB1—Integrated Pancreatic Cancer Pathway—SIRT1—brain cancer	3.48e-05	0.000677	CbGpPWpGaD
Methadone—OPRM1—Signaling Pathways—PTCH2—brain cancer	3.48e-05	0.000676	CbGpPWpGaD
Methadone—CYP19A1—Integrated Breast Cancer Pathway—MYC—brain cancer	3.48e-05	0.000675	CbGpPWpGaD
Methadone—ABCB1—HIF-1-alpha transcription factor network—VEGFA—brain cancer	3.47e-05	0.000674	CbGpPWpGaD
Methadone—OPRK1—Signaling by GPCR—TRPC6—brain cancer	3.46e-05	0.000672	CbGpPWpGaD
Methadone—ABCB1—Integrated Pancreatic Cancer Pathway—CCNE1—brain cancer	3.44e-05	0.000668	CbGpPWpGaD
Methadone—OPRK1—Signaling by GPCR—SMO—brain cancer	3.4e-05	0.000661	CbGpPWpGaD
Methadone—OPRK1—Signaling by GPCR—PTCH1—brain cancer	3.4e-05	0.000661	CbGpPWpGaD
Methadone—CYP1A2—Aryl Hydrocarbon Receptor—MYC—brain cancer	3.4e-05	0.000661	CbGpPWpGaD
Methadone—CYP19A1—Integrated Breast Cancer Pathway—EGFR—brain cancer	3.4e-05	0.000661	CbGpPWpGaD
Methadone—OPRM1—Signaling Pathways—HES5—brain cancer	3.37e-05	0.000654	CbGpPWpGaD
Methadone—OPRD1—Signaling Pathways—GLI1—brain cancer	3.35e-05	0.00065	CbGpPWpGaD
Methadone—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—brain cancer	3.33e-05	0.000646	CbGpPWpGaD
Methadone—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—brain cancer	3.33e-05	0.000646	CbGpPWpGaD
Methadone—CYP2C8—Metabolism of lipids and lipoproteins—IDH1—brain cancer	3.28e-05	0.000637	CbGpPWpGaD
Methadone—OPRM1—Signaling Pathways—STRADA—brain cancer	3.27e-05	0.000635	CbGpPWpGaD
Methadone—OPRD1—GPCR downstream signaling—VAV1—brain cancer	3.26e-05	0.000633	CbGpPWpGaD
Methadone—OPRK1—Signaling Pathways—ABR—brain cancer	3.23e-05	0.000627	CbGpPWpGaD
Methadone—OPRM1—GPCR downstream signaling—TRPC6—brain cancer	3.22e-05	0.000626	CbGpPWpGaD
Methadone—ABCB1—Integrated Pancreatic Cancer Pathway—PDGFRA—brain cancer	3.2e-05	0.000621	CbGpPWpGaD
Methadone—CYP3A7—Metabolism—CYP2C9—brain cancer	3.19e-05	0.000619	CbGpPWpGaD
Methadone—OPRD1—Signaling Pathways—SUFU—brain cancer	3.17e-05	0.000616	CbGpPWpGaD
Methadone—CYP19A1—Metabolism—BSG—brain cancer	3.12e-05	0.000606	CbGpPWpGaD
Methadone—OPRK1—Signaling Pathways—GLI2—brain cancer	3.12e-05	0.000606	CbGpPWpGaD
Methadone—CYP1A2—Metabolism of lipids and lipoproteins—CYP2C9—brain cancer	3.12e-05	0.000606	CbGpPWpGaD
Methadone—OPRD1—Signaling Pathways—GFAP—brain cancer	3.06e-05	0.000594	CbGpPWpGaD
Methadone—ABCB1—Integrated Pancreatic Cancer Pathway—PCNA—brain cancer	3.05e-05	0.000592	CbGpPWpGaD
Methadone—OPRM1—Signaling by GPCR—SHH—brain cancer	3.03e-05	0.000589	CbGpPWpGaD
Methadone—ABCB1—Allograft Rejection—VEGFA—brain cancer	3.01e-05	0.000584	CbGpPWpGaD
Methadone—OPRD1—Signaling by GPCR—VAV1—brain cancer	2.96e-05	0.000574	CbGpPWpGaD
Methadone—OPRK1—Signaling Pathways—GLI1—brain cancer	2.93e-05	0.00057	CbGpPWpGaD
Methadone—CYP2C19—Metabolism of lipids and lipoproteins—IDH1—brain cancer	2.93e-05	0.000568	CbGpPWpGaD
Methadone—OPRM1—Signaling by GPCR—TRPC6—brain cancer	2.93e-05	0.000568	CbGpPWpGaD
Methadone—OPRD1—Signaling Pathways—HEY1—brain cancer	2.9e-05	0.000563	CbGpPWpGaD
Methadone—OPRM1—Signaling by GPCR—PTCH1—brain cancer	2.88e-05	0.000559	CbGpPWpGaD
Methadone—OPRM1—Signaling by GPCR—SMO—brain cancer	2.88e-05	0.000559	CbGpPWpGaD
Methadone—OPRK1—GPCR downstream signaling—VAV1—brain cancer	2.86e-05	0.000555	CbGpPWpGaD
Methadone—CYP19A1—Integrated Breast Cancer Pathway—TP53—brain cancer	2.86e-05	0.000555	CbGpPWpGaD
Methadone—OPRD1—Signaling Pathways—DLL1—brain cancer	2.84e-05	0.000552	CbGpPWpGaD
Methadone—OPRK1—Signaling Pathways—SUFU—brain cancer	2.78e-05	0.00054	CbGpPWpGaD
Methadone—CYP2C18—Metabolism—ENO2—brain cancer	2.77e-05	0.000538	CbGpPWpGaD
Methadone—OPRM1—Signaling Pathways—ABR—brain cancer	2.73e-05	0.00053	CbGpPWpGaD
Methadone—CYP3A7—Metabolism—BSG—brain cancer	2.71e-05	0.000527	CbGpPWpGaD
Methadone—CYP19A1—Metabolism—IDH1—brain cancer	2.69e-05	0.000522	CbGpPWpGaD
Methadone—OPRK1—Signaling Pathways—GFAP—brain cancer	2.68e-05	0.000521	CbGpPWpGaD
Methadone—CYP2C9—Metabolism of lipids and lipoproteins—IDH1—brain cancer	2.67e-05	0.000518	CbGpPWpGaD
Methadone—OPRM1—Signaling Pathways—GLI2—brain cancer	2.64e-05	0.000512	CbGpPWpGaD
Methadone—ABCB1—Integrated Pancreatic Cancer Pathway—CDK4—brain cancer	2.63e-05	0.000512	CbGpPWpGaD
Methadone—OPRK1—Signaling by GPCR—VAV1—brain cancer	2.59e-05	0.000504	CbGpPWpGaD
Methadone—OPRK1—Signaling Pathways—HEY1—brain cancer	2.54e-05	0.000494	CbGpPWpGaD
Methadone—OPRK1—Signaling Pathways—DLL1—brain cancer	2.49e-05	0.000484	CbGpPWpGaD
Methadone—ABCB1—Integrated Pancreatic Cancer Pathway—APC—brain cancer	2.48e-05	0.000482	CbGpPWpGaD
Methadone—OPRM1—Signaling Pathways—GLI1—brain cancer	2.48e-05	0.000481	CbGpPWpGaD
Methadone—OPRD1—Signaling Pathways—SHH—brain cancer	2.42e-05	0.00047	CbGpPWpGaD
Methadone—OPRM1—GPCR downstream signaling—VAV1—brain cancer	2.41e-05	0.000469	CbGpPWpGaD
Methadone—CYP2B6—Metabolism—CYP2C9—brain cancer	2.36e-05	0.000458	CbGpPWpGaD
Methadone—OPRM1—Signaling Pathways—SUFU—brain cancer	2.35e-05	0.000456	CbGpPWpGaD
Methadone—CYP3A7—Metabolism—IDH1—brain cancer	2.33e-05	0.000453	CbGpPWpGaD
Methadone—OPRD1—Signaling Pathways—TRPC6—brain cancer	2.33e-05	0.000453	CbGpPWpGaD
Methadone—CYP3A5—Metabolism—CYP2C9—brain cancer	2.31e-05	0.000448	CbGpPWpGaD
Methadone—OPRD1—Signaling Pathways—SMO—brain cancer	2.29e-05	0.000445	CbGpPWpGaD
Methadone—OPRD1—Signaling Pathways—PTCH1—brain cancer	2.29e-05	0.000445	CbGpPWpGaD
Methadone—CYP1A2—Metabolism of lipids and lipoproteins—IDH1—brain cancer	2.28e-05	0.000443	CbGpPWpGaD
Methadone—OPRM1—Signaling Pathways—GFAP—brain cancer	2.27e-05	0.00044	CbGpPWpGaD
Methadone—OPRM1—Signaling by GPCR—VAV1—brain cancer	2.19e-05	0.000426	CbGpPWpGaD
Methadone—CYP19A1—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	2.19e-05	0.000425	CbGpPWpGaD
Methadone—OPRM1—Signaling Pathways—HEY1—brain cancer	2.15e-05	0.000417	CbGpPWpGaD
Methadone—CYP19A1—Metabolism—ENO2—brain cancer	2.12e-05	0.000412	CbGpPWpGaD
Methadone—OPRK1—Signaling Pathways—SHH—brain cancer	2.12e-05	0.000412	CbGpPWpGaD
Methadone—OPRM1—Signaling Pathways—DLL1—brain cancer	2.11e-05	0.000409	CbGpPWpGaD
Methadone—ABCB1—Transmembrane transport of small molecules—TRPC6—brain cancer	2.07e-05	0.000402	CbGpPWpGaD
Methadone—OPRD1—GPCR downstream signaling—PIK3CG—brain cancer	2.07e-05	0.000402	CbGpPWpGaD
Methadone—OPRK1—Signaling Pathways—TRPC6—brain cancer	2.04e-05	0.000397	CbGpPWpGaD
Methadone—OPRK1—Signaling Pathways—PTCH1—brain cancer	2.01e-05	0.00039	CbGpPWpGaD
Methadone—OPRK1—Signaling Pathways—SMO—brain cancer	2.01e-05	0.00039	CbGpPWpGaD
Methadone—CYP2B6—Metabolism—BSG—brain cancer	2.01e-05	0.000389	CbGpPWpGaD
Methadone—CYP2C8—Metabolism—CYP2C9—brain cancer	2e-05	0.000388	CbGpPWpGaD
Methadone—CYP3A5—Metabolism—BSG—brain cancer	1.96e-05	0.000381	CbGpPWpGaD
Methadone—ABCB1—Integrated Pancreatic Cancer Pathway—ERBB2—brain cancer	1.93e-05	0.000374	CbGpPWpGaD
Methadone—OPRD1—Signaling by GPCR—PIK3CG—brain cancer	1.88e-05	0.000365	CbGpPWpGaD
Methadone—CYP3A7—Metabolism—ENO2—brain cancer	1.84e-05	0.000358	CbGpPWpGaD
Methadone—OPRD1—Signaling Pathways—NOTCH2—brain cancer	1.83e-05	0.000356	CbGpPWpGaD
Methadone—OPRK1—GPCR downstream signaling—PIK3CG—brain cancer	1.81e-05	0.000352	CbGpPWpGaD
Methadone—OPRM1—Signaling Pathways—SHH—brain cancer	1.79e-05	0.000348	CbGpPWpGaD
Methadone—CYP2C19—Metabolism—CYP2C9—brain cancer	1.78e-05	0.000346	CbGpPWpGaD
Methadone—OPRD1—Signaling Pathways—VAV1—brain cancer	1.75e-05	0.000339	CbGpPWpGaD
Methadone—ABCB1—Metabolism—CYP2C9—brain cancer	1.74e-05	0.000338	CbGpPWpGaD
Methadone—OPRM1—Signaling Pathways—TRPC6—brain cancer	1.73e-05	0.000336	CbGpPWpGaD
Methadone—CYP2B6—Metabolism—IDH1—brain cancer	1.72e-05	0.000335	CbGpPWpGaD
Methadone—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—brain cancer	1.7e-05	0.00033	CbGpPWpGaD
Methadone—OPRM1—Signaling Pathways—PTCH1—brain cancer	1.7e-05	0.00033	CbGpPWpGaD
Methadone—OPRM1—Signaling Pathways—SMO—brain cancer	1.7e-05	0.00033	CbGpPWpGaD
Methadone—CYP2C8—Metabolism—BSG—brain cancer	1.7e-05	0.00033	CbGpPWpGaD
Methadone—CYP3A5—Metabolism—IDH1—brain cancer	1.69e-05	0.000327	CbGpPWpGaD
Methadone—ABCB1—Integrated Pancreatic Cancer Pathway—CTNNB1—brain cancer	1.69e-05	0.000327	CbGpPWpGaD
Methadone—OPRK1—Signaling by GPCR—PIK3CG—brain cancer	1.65e-05	0.00032	CbGpPWpGaD
Methadone—CYP2D6—Metabolism—CYP2C9—brain cancer	1.64e-05	0.000318	CbGpPWpGaD
Methadone—OPRK1—Signaling Pathways—NOTCH2—brain cancer	1.61e-05	0.000312	CbGpPWpGaD
Methadone—OPRM1—GPCR downstream signaling—PIK3CG—brain cancer	1.53e-05	0.000298	CbGpPWpGaD
Methadone—OPRK1—Signaling Pathways—VAV1—brain cancer	1.53e-05	0.000298	CbGpPWpGaD
Methadone—CYP2C19—Metabolism—BSG—brain cancer	1.52e-05	0.000294	CbGpPWpGaD
Methadone—OPRD1—Signaling Pathways—HES1—brain cancer	1.5e-05	0.000292	CbGpPWpGaD
Methadone—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—brain cancer	1.48e-05	0.000288	CbGpPWpGaD
Methadone—ABCB1—Metabolism—BSG—brain cancer	1.48e-05	0.000287	CbGpPWpGaD
Methadone—CYP2C8—Metabolism—IDH1—brain cancer	1.46e-05	0.000284	CbGpPWpGaD
Methadone—OPRD1—GPCR downstream signaling—IL2—brain cancer	1.46e-05	0.000283	CbGpPWpGaD
Methadone—OPRD1—Signaling Pathways—PDGFRA—brain cancer	1.43e-05	0.000278	CbGpPWpGaD
Methadone—CYP2D6—Metabolism—BSG—brain cancer	1.39e-05	0.000271	CbGpPWpGaD
Methadone—OPRM1—Signaling by GPCR—PIK3CG—brain cancer	1.39e-05	0.00027	CbGpPWpGaD
Methadone—OPRD1—Signaling Pathways—SPP1—brain cancer	1.39e-05	0.00027	CbGpPWpGaD
Methadone—CYP1A2—Metabolism—CYP2C9—brain cancer	1.39e-05	0.00027	CbGpPWpGaD
Methadone—CYP2C9—Metabolism—BSG—brain cancer	1.38e-05	0.000268	CbGpPWpGaD
Methadone—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—brain cancer	1.36e-05	0.000265	CbGpPWpGaD
Methadone—CYP2B6—Metabolism—ENO2—brain cancer	1.36e-05	0.000265	CbGpPWpGaD
Methadone—OPRM1—Signaling Pathways—NOTCH2—brain cancer	1.36e-05	0.000264	CbGpPWpGaD
Methadone—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—brain cancer	1.33e-05	0.000259	CbGpPWpGaD
Methadone—CYP3A5—Metabolism—ENO2—brain cancer	1.33e-05	0.000259	CbGpPWpGaD
Methadone—OPRD1—Signaling by GPCR—IL2—brain cancer	1.32e-05	0.000257	CbGpPWpGaD
Methadone—OPRK1—Signaling Pathways—HES1—brain cancer	1.32e-05	0.000256	CbGpPWpGaD
Methadone—CYP2C19—Metabolism—IDH1—brain cancer	1.3e-05	0.000253	CbGpPWpGaD
Methadone—OPRM1—Signaling Pathways—VAV1—brain cancer	1.29e-05	0.000251	CbGpPWpGaD
Methadone—OPRK1—GPCR downstream signaling—IL2—brain cancer	1.28e-05	0.000248	CbGpPWpGaD
Methadone—ABCB1—Metabolism—IDH1—brain cancer	1.27e-05	0.000247	CbGpPWpGaD
Methadone—CYP2C18—Metabolism—PIK3CG—brain cancer	1.27e-05	0.000247	CbGpPWpGaD
Methadone—OPRD1—Signaling Pathways—IRS2—brain cancer	1.26e-05	0.000244	CbGpPWpGaD
Methadone—OPRK1—Signaling Pathways—PDGFRA—brain cancer	1.25e-05	0.000244	CbGpPWpGaD
Methadone—OPRK1—Signaling Pathways—SPP1—brain cancer	1.22e-05	0.000237	CbGpPWpGaD
Methadone—CYP2D6—Metabolism—IDH1—brain cancer	1.2e-05	0.000233	CbGpPWpGaD
Methadone—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	1.19e-05	0.000231	CbGpPWpGaD
Methadone—CYP2C9—Metabolism—IDH1—brain cancer	1.19e-05	0.000231	CbGpPWpGaD
Methadone—CYP1A2—Metabolism—BSG—brain cancer	1.18e-05	0.000229	CbGpPWpGaD
Methadone—OPRK1—Signaling by GPCR—IL2—brain cancer	1.16e-05	0.000225	CbGpPWpGaD
Methadone—CYP2C8—Metabolism—ENO2—brain cancer	1.15e-05	0.000224	CbGpPWpGaD
Methadone—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—brain cancer	1.12e-05	0.000218	CbGpPWpGaD
Methadone—OPRM1—Signaling Pathways—HES1—brain cancer	1.11e-05	0.000216	CbGpPWpGaD
Methadone—OPRD1—Signaling Pathways—APC—brain cancer	1.11e-05	0.000215	CbGpPWpGaD
Methadone—OPRD1—Signaling Pathways—PIK3CG—brain cancer	1.11e-05	0.000215	CbGpPWpGaD
Methadone—OPRK1—Signaling Pathways—IRS2—brain cancer	1.1e-05	0.000214	CbGpPWpGaD
Methadone—OPRM1—GPCR downstream signaling—IL2—brain cancer	1.08e-05	0.000209	CbGpPWpGaD
Methadone—CYP3A4—Metabolism—CYP2C9—brain cancer	1.07e-05	0.000208	CbGpPWpGaD
Methadone—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	1.06e-05	0.000206	CbGpPWpGaD
Methadone—OPRM1—Signaling Pathways—PDGFRA—brain cancer	1.06e-05	0.000206	CbGpPWpGaD
Methadone—CYP2C19—Metabolism—ENO2—brain cancer	1.03e-05	0.0002	CbGpPWpGaD
Methadone—OPRM1—Signaling Pathways—SPP1—brain cancer	1.03e-05	0.0002	CbGpPWpGaD
Methadone—CYP1A2—Metabolism—IDH1—brain cancer	1.02e-05	0.000197	CbGpPWpGaD
Methadone—OPRD1—Signaling by GPCR—EGFR—brain cancer	1.01e-05	0.000196	CbGpPWpGaD
Methadone—ABCB1—Metabolism—ENO2—brain cancer	1.01e-05	0.000195	CbGpPWpGaD
Methadone—OPRM1—Signaling by GPCR—IL2—brain cancer	9.79e-06	0.00019	CbGpPWpGaD
Methadone—CYP19A1—Metabolism—PIK3CG—brain cancer	9.74e-06	0.000189	CbGpPWpGaD
Methadone—OPRK1—Signaling Pathways—PIK3CG—brain cancer	9.73e-06	0.000189	CbGpPWpGaD
Methadone—OPRK1—Signaling Pathways—APC—brain cancer	9.73e-06	0.000189	CbGpPWpGaD
Methadone—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	9.68e-06	0.000188	CbGpPWpGaD
Methadone—CYP2D6—Metabolism—ENO2—brain cancer	9.48e-06	0.000184	CbGpPWpGaD
Methadone—CYP2C9—Metabolism—ENO2—brain cancer	9.39e-06	0.000182	CbGpPWpGaD
Methadone—OPRM1—Signaling Pathways—IRS2—brain cancer	9.31e-06	0.000181	CbGpPWpGaD
Methadone—CYP3A4—Metabolism—BSG—brain cancer	9.11e-06	0.000177	CbGpPWpGaD
Methadone—OPRK1—Signaling by GPCR—EGFR—brain cancer	8.86e-06	0.000172	CbGpPWpGaD
Methadone—OPRD1—Signaling Pathways—RELA—brain cancer	8.67e-06	0.000168	CbGpPWpGaD
Methadone—OPRD1—Signaling Pathways—ERBB2—brain cancer	8.61e-06	0.000167	CbGpPWpGaD
Methadone—CYP3A7—Metabolism—PIK3CG—brain cancer	8.46e-06	0.000164	CbGpPWpGaD
Methadone—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	8.27e-06	0.000161	CbGpPWpGaD
Methadone—OPRM1—Signaling Pathways—PIK3CG—brain cancer	8.22e-06	0.00016	CbGpPWpGaD
Methadone—OPRM1—Signaling Pathways—APC—brain cancer	8.22e-06	0.00016	CbGpPWpGaD
Methadone—CYP1A2—Metabolism—ENO2—brain cancer	8.03e-06	0.000156	CbGpPWpGaD
Methadone—CYP3A4—Metabolism—IDH1—brain cancer	7.84e-06	0.000152	CbGpPWpGaD
Methadone—OPRD1—Signaling Pathways—IL2—brain cancer	7.81e-06	0.000152	CbGpPWpGaD
Methadone—OPRD1—Signaling Pathways—CCND1—brain cancer	7.61e-06	0.000148	CbGpPWpGaD
Methadone—OPRK1—Signaling Pathways—RELA—brain cancer	7.6e-06	0.000148	CbGpPWpGaD
Methadone—OPRK1—Signaling Pathways—ERBB2—brain cancer	7.55e-06	0.000147	CbGpPWpGaD
Methadone—OPRD1—Signaling Pathways—CTNNB1—brain cancer	7.54e-06	0.000146	CbGpPWpGaD
Methadone—OPRM1—Signaling by GPCR—EGFR—brain cancer	7.49e-06	0.000145	CbGpPWpGaD
Methadone—OPRK1—Signaling Pathways—IL2—brain cancer	6.85e-06	0.000133	CbGpPWpGaD
Methadone—OPRK1—Signaling Pathways—CCND1—brain cancer	6.67e-06	0.00013	CbGpPWpGaD
Methadone—OPRD1—Signaling Pathways—VEGFA—brain cancer	6.63e-06	0.000129	CbGpPWpGaD
Methadone—OPRK1—Signaling Pathways—CTNNB1—brain cancer	6.61e-06	0.000128	CbGpPWpGaD
Methadone—OPRD1—Signaling Pathways—STAT3—brain cancer	6.57e-06	0.000128	CbGpPWpGaD
Methadone—OPRM1—Signaling Pathways—RELA—brain cancer	6.42e-06	0.000125	CbGpPWpGaD
Methadone—OPRM1—Signaling Pathways—ERBB2—brain cancer	6.38e-06	0.000124	CbGpPWpGaD
Methadone—CYP2B6—Metabolism—PIK3CG—brain cancer	6.25e-06	0.000121	CbGpPWpGaD
Methadone—CYP3A4—Metabolism—ENO2—brain cancer	6.2e-06	0.00012	CbGpPWpGaD
Methadone—CYP3A5—Metabolism—PIK3CG—brain cancer	6.11e-06	0.000119	CbGpPWpGaD
Methadone—OPRD1—Signaling Pathways—MYC—brain cancer	6.1e-06	0.000119	CbGpPWpGaD
Methadone—OPRD1—Signaling Pathways—EGFR—brain cancer	5.97e-06	0.000116	CbGpPWpGaD
Methadone—OPRK1—Signaling Pathways—VEGFA—brain cancer	5.82e-06	0.000113	CbGpPWpGaD
Methadone—OPRM1—Signaling Pathways—IL2—brain cancer	5.79e-06	0.000112	CbGpPWpGaD
Methadone—OPRK1—Signaling Pathways—STAT3—brain cancer	5.76e-06	0.000112	CbGpPWpGaD
Methadone—OPRM1—Signaling Pathways—CCND1—brain cancer	5.64e-06	0.00011	CbGpPWpGaD
Methadone—OPRM1—Signaling Pathways—CTNNB1—brain cancer	5.59e-06	0.000108	CbGpPWpGaD
Methadone—OPRK1—Signaling Pathways—MYC—brain cancer	5.35e-06	0.000104	CbGpPWpGaD
Methadone—CYP2C8—Metabolism—PIK3CG—brain cancer	5.29e-06	0.000103	CbGpPWpGaD
Methadone—OPRK1—Signaling Pathways—EGFR—brain cancer	5.24e-06	0.000102	CbGpPWpGaD
Methadone—OPRD1—Signaling Pathways—TP53—brain cancer	5.01e-06	9.74e-05	CbGpPWpGaD
Methadone—OPRM1—Signaling Pathways—VEGFA—brain cancer	4.92e-06	9.55e-05	CbGpPWpGaD
Methadone—OPRM1—Signaling Pathways—STAT3—brain cancer	4.87e-06	9.45e-05	CbGpPWpGaD
Methadone—CYP2C19—Metabolism—PIK3CG—brain cancer	4.73e-06	9.18e-05	CbGpPWpGaD
Methadone—ABCB1—Metabolism—PIK3CG—brain cancer	4.61e-06	8.96e-05	CbGpPWpGaD
Methadone—OPRM1—Signaling Pathways—MYC—brain cancer	4.52e-06	8.79e-05	CbGpPWpGaD
Methadone—OPRM1—Signaling Pathways—EGFR—brain cancer	4.42e-06	8.59e-05	CbGpPWpGaD
Methadone—OPRK1—Signaling Pathways—TP53—brain cancer	4.4e-06	8.54e-05	CbGpPWpGaD
Methadone—CYP2D6—Metabolism—PIK3CG—brain cancer	4.35e-06	8.44e-05	CbGpPWpGaD
Methadone—CYP2C9—Metabolism—PIK3CG—brain cancer	4.31e-06	8.37e-05	CbGpPWpGaD
Methadone—OPRM1—Signaling Pathways—TP53—brain cancer	3.72e-06	7.22e-05	CbGpPWpGaD
Methadone—CYP1A2—Metabolism—PIK3CG—brain cancer	3.68e-06	7.15e-05	CbGpPWpGaD
Methadone—CYP3A4—Metabolism—PIK3CG—brain cancer	2.84e-06	5.52e-05	CbGpPWpGaD
